Disclosure of interest: Shubham Biyani: nothing to disclose Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.02 - SAH, ANEURYSMS AND VASCULAR MALFORMATIONS P150 - ESOC25-441 MINIMAL GROWTH RISK IN SMALL INCIDENTAL CAROTID OPHTHALMIC ANEURYSMS: REVISITING SURVEILLANCE INTERVALS FOR OPTIMISED MANAGEMENT Ronil Chandra 1,2 , Fergus Taylor 1 , Seana Gall 3,4 , Leon Lai 2,5 , Christopher Photopoulos 1 , Kenny Li 1 , Shreyas Honavar 1 , Lee-Anne Slater 1,6 , Thanh Phan 4,7 1 NeuroInterventional Radiology, Monash Medical Centre, Monash Health, Melbourne, Australia, 2 Department of Surgery, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 3 Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, 4 Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 5 Neurosurgery, Monash Medical Centre, Monash Health, Melbourne, Australia, 6 Department of Radiology and Radiological Sciences, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 7 Neurology, Monash Medical Centre, Monash Health, Melbourne, Australia Background and Aims: The optimal intervals for radiological surveillance of small incidental carotid ophthalmic artery (CoA) aneurysms remain uncertain, with current guidelines recommending annual or biennial imaging
The Hospira brand represents the gold standard in pharmaceutical-grade water preparations, with extensive quality-control testing including sterility assurance, endotoxin limits, particulate matter analysis, and precise benzyl alcohol concentration verification
Keep topical serums away from heat and light, refrigerate after opening when possible
S2CID 13007622
avoid moisture uptake For stock solutions, dissolve in water or dilute acid (e.g
